Page last updated: 2024-09-03

mono-n-demethyladinazolam and uric acid

mono-n-demethyladinazolam has been researched along with uric acid in 3 studies

*Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN. [MeSH]

*Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN. [MeSH]

Compound Research Comparison

Studies
(mono-n-demethyladinazolam)
Trials
(mono-n-demethyladinazolam)
Recent Studies (post-2010)
(mono-n-demethyladinazolam)
Studies
(uric acid)
Trials
(uric acid)
Recent Studies (post-2010) (uric acid)
2012027,9801,7179,982

Protein Interaction Comparison

ProteinTaxonomymono-n-demethyladinazolam (IC50)uric acid (IC50)
Solute carrier family 2, facilitated glucose transporter member 9Homo sapiens (human)300

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fleishaker, JC; Friedman, H; Hulst, LK; Smith, TC1
Fleishaker, JC; Friedman, H; Pollock, SR; Smith, TC1
Brouwer, KL; Fleishaker, JC; Golden, PL; Jewell, RC; Lyon, J; Millikin, S; Warner, PE1

Trials

3 trial(s) available for mono-n-demethyladinazolam and uric acid

ArticleYear
Clinical pharmacology of adinazolam and N-desmethyladinazolam mesylate following single intravenous infusions of each compound in health volunteers.
    European journal of clinical pharmacology, 1992, Volume: 42, Issue:3

    Topics: Adolescent; Adult; Analysis of Variance; Anti-Anxiety Agents; Benzodiazepines; Dose-Response Relationship, Drug; Humans; Injections, Intravenous; Male; Middle Aged; Psychomotor Performance; Reference Values; Uric Acid

1992
Clinical pharmacology of adinazolam and N-desmethyladinazolam mesylate after single oral doses of each compound in healthy volunteers.
    Clinical pharmacology and therapeutics, 1990, Volume: 48, Issue:6

    Topics: Administration, Oral; Adolescent; Adult; Anti-Anxiety Agents; Antidepressive Agents; Benzodiazepines; Humans; Male; Psychomotor Performance; Reference Values; Uric Acid

1990
Effects of probenecid on the pharmacokinetics and pharmacodynamics of adinazolam in humans.
    Clinical pharmacology and therapeutics, 1994, Volume: 56, Issue:2

    Topics: Administration, Oral; Adult; Anti-Anxiety Agents; Antidepressive Agents; Benzodiazepines; Double-Blind Method; Drug Interactions; Drug Synergism; Humans; Kidney; Male; Memory, Short-Term; Probenecid; Psychomotor Performance; Uric Acid

1994